Literature DB >> 26465100

Kawasaki Disease in Germany: A Prospective, Population-based Study Adjusted for Underreporting.

André Jakob1, Jane Whelan, Matthaeus Kordecki, Reinhard Berner, Brigitte Stiller, Raoul Arnold, Rudiger von Kries, Elena Neumann, Nicholas Roubinis, Mirna Robert, Jochen Grohmann, René Höhn, Markus Hufnagel.   

Abstract

BACKGROUND: National estimates of Kawasaki disease (KD) incidence often do not include incomplete cases (diagnosed based on only laboratory or echocardiographic criteria), and/or they rely on retrospective case reports and data registries where underreporting is known to be a problem.
METHODS: We conducted a prospective nationwide KD surveillance study in children younger than 5 years through the hospital-based German Pediatric Surveillance Unit (ESPED). We accounted for underreporting through applying capture-recapture methodology in 2 federal states using hospital discharge records with KD International Statistical Classification of Diseases and Related Health Problems 10th revision code (ie, M30.3). KD diagnosis (complete and incomplete) was established according to the American Heart Association criteria, 2004.
RESULTS: Incidence of KD, corrected for underreporting, was 7.2 of 100,000 in children younger than 5 years in Germany. Underreporting to ESPED was estimated at 37%-44%. Overall, 315 validated KD cases were reported. Of the 64 (20%) incomplete cases, 58% (37/64) were detected through echocardiographic findings and 42% (27/64) through laboratory criteria alone. Incomplete cases were younger than complete cases (1.2 vs. 2.0 years, P = 0.0001) and had more coronary aneurysms (43% vs. 11%, P = 0.0001).
CONCLUSIONS: A substantial number of incomplete KD cases were diagnosed based on the laboratory and echocardiographic criteria only. This was particularly the case in relation to infants younger than 1 year-an age group known to have an increased risk of developing coronary aneurysms. In addition, we found a high rate of underreporting to national Pediatric Surveillance Units. We suggest that improved surveillance and development of better diagnostic tests remain a high priority.

Entities:  

Mesh:

Year:  2016        PMID: 26465100     DOI: 10.1097/INF.0000000000000953

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  22 in total

1.  Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease.

Authors:  André Jakob; Eva Schachinger; Simon Klau; Anja Lehner; Sarah Ulrich; Brigitte Stiller; Barbara Zieger
Journal:  Eur J Pediatr       Date:  2019-11-23       Impact factor: 3.183

2.  The factors affecting the disease course in Kawasaki disease.

Authors:  Elif Arslanoglu Aydin; Ilker Ertugrul; Yelda Bilginer; Ezgi Deniz Batu; Hafize Emine Sonmez; Selcan Demir; Zehra Serap Arici; Erdal Sag; Dursun Alehan; Seza Ozen
Journal:  Rheumatol Int       Date:  2019-05-28       Impact factor: 2.631

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

4.  Kawasaki disease in Spanish paediatric population and synoptic weather types: an observational study.

Authors:  Leyre Riancho-Zarrabeitia; Domingo F Rasilla; Dominic Royé; Pablo Fdez-Arroyabe; Ana Santurtún
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

5.  Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis.

Authors:  Christian Karagiannidis; Leif-Erik Sander; Marcus A Mall; Reinhard Busse
Journal:  Infection       Date:  2022-06-30       Impact factor: 7.455

Review 6.  Dissecting Kawasaki disease: a state-of-the-art review.

Authors:  S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers
Journal:  Eur J Pediatr       Date:  2017-06-27       Impact factor: 3.183

Review 7.  The global epidemiology of Kawasaki disease: Review and future perspectives.

Authors:  Ming-Tai Lin; Mei-Hwan Wu
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

8.  The Most Common Clinical Features of Kawasaki Disease Patients in King Abdulaziz Medical City.

Authors:  Khalid Talal Alghamdi; Rahaf Abdulmalik Waggass; Syed Sameer Aga; Abdulaziz Ahmed Alrohaili; Ali Hassan Alaidroos; Mohammed Dakhilallah Alghamdi; Mohannd Khalid Algamdi; Ashwaq Talal Alghamdi
Journal:  Cureus       Date:  2021-05-19

9.  Influence of Latitude on the Prevalence of Kawasaki Disease: A Retrospective Cohort Study from the Taiwan National Health Insurance Database and Review of the Literature.

Authors:  Chaw-Liang Chang; Chih-Shung Wong; Yi-Chen Yang; Nan-Chang Chiu
Journal:  Int J Environ Res Public Health       Date:  2018-04-25       Impact factor: 3.390

Review 10.  Kawasaki Disease.

Authors:  Christian M Hedrich; Anja Schnabel; Toni Hospach
Journal:  Front Pediatr       Date:  2018-07-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.